Home

Kidney Disease: Improving Global Outcomes (KDIGO)

Website: www.kdigo.org 

Evidence Review: See KDIGO Evidence Rating Position Statement

Title/Publication

Sub-Topics Covered

Published

Coordinator/Workgroup

Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease

Published: Kidney Int. (2008) 72 (Suppl 109), S1—S99

  1. Detection and evaluation of HCV in CKD
  2. Treatment of HCV infection in patients with CKD
  3. Preventing HCV transmission in hemodialysis units
  4. Management of HCV-infected patients before and after kidney transplantation
  5. Diagnosis and management of kidney diseases associated with HCV infection

Apr., 2008

Workgroup Chairs:
Michel Jadoul
David Roth

Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease related Mineral and Bone Disorders (CKD-MBD)

Published: Kidney Int. (2009) 76 (Suppl 113), S1—S9130

  1. Diagnosis of CKD-MBD: Biochemical Abnormalities
  2. Diagnosis of CKD-MBD: Bone
  3. Diagnosis of CKD-MBD: Vascular Calcification
  4. Treatment of CKD-MBD Targeted at Lowering High Serum Phosphorus and Maintaining Serum Calcium
  5. Treatment of Abnormal PTH Levels in CKD-MBD
  6. Treatment of Bone with Bisphosphonates, Other Osteoporosis Medications, and Growth Hormone
  7. Evaluation and Treatment of Kidney Transplant Bone Disease
  8. Summary and Research Recommendations

August, 2009

Workgroup Chairs:
Tilman Drüeke
Sharon Moe

Care of the Kidney Transplant Recipient

Published: Am J of Transplant (2009) 3 (Supple 9) S1-S155

  1. Induction Therapy
  2. Initial Maintenance Immunosuppressive Medications
  3. Long-Term Maintenance Immunosuppressive Medications
  4. Strategies to Reduce Drug Costs
  5. Monitoring Immunosuppressive Medications
  6. Treatment of Acute Rejection
  7. Treatment of Chronic Allograft Injury
  8. Monitoring Kidney Allograft Function
  9. Kidney Allograft Biopsy
  10. Recurrent Kidney Disease
  11. Preventing, Detecting, and Treating Nonadherence
  12. Vaccination
  13. Viral Diseases
  14. Other Infections
  15. Screening for New-Onset Diabetes after Transplantation
  16. Hypertension, Dyslipidemias, Tobacco Use, and Obesity
  17. Cardiovascular Disease Management
  18. Cancer of the Skin and Lip
  19. Non–Skin Malignancies
  20. Managing Cancer with Reduction of Immunosuppressive Medication
  21. Transplant Bone Disease
  22. Hematological Complications
  23. Hyperuricemia and Gout
  24. Growth and Development
  25. Sexual Function and Fertility
  26. Lifestyle
  27. Mental Health

May, 2009

Workgroup Chairs:
Bertram Kasiske
Martin Zeier

Acute Kidney Injury (AKI),

 

Under
Development

Workgroup Chairs:
John Kellum
Norbert Lameire

Glomerulonephritis

 

Under
Development

Workgroup Chairs:
John Feehally
Daniel Cattran

Hypertension in CKD

 

Under
Development

Workgroup Chairs:
Gavin Becker
David Wheeler

CKD

 

Under
Development

Workgroup Chairs:
Adeera Levin
Paul Stevens

Anemia in CKD

 

Under
Development

Workgroup Chairs:
John McMurray
Patrick Parfrey